These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 23279219

  • 1. Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse.
    Westwood JP, Webster H, McGuckin S, McDonald V, Machin SJ, Scully M.
    J Thromb Haemost; 2013 Mar; 11(3):481-90. PubMed ID: 23279219
    [Abstract] [Full Text] [Related]

  • 2. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features.
    Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN.
    Pediatr Blood Cancer; 2013 Oct; 60(10):1676-82. PubMed ID: 23729372
    [Abstract] [Full Text] [Related]

  • 3. A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.
    Clark WF, Rock G, Barth D, Arnold DM, Webert KE, Yenson PR, Kelton JG, Li L, Foley SR, members of Canadian Apheresis Group.
    Br J Haematol; 2015 Jul; 170(2):208-17. PubMed ID: 25855259
    [Abstract] [Full Text] [Related]

  • 4. Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura.
    Hie M, Gay J, Galicier L, Provôt F, Presne C, Poullin P, Bonmarchand G, Wynckel A, Benhamou Y, Vanhille P, Servais A, Bordessoule D, Coindre JP, Hamidou M, Vernant JP, Veyradier A, Coppo P, French Thrombotic Microangiopathies Reference Centre.
    Blood; 2014 Jul 10; 124(2):204-10. PubMed ID: 24869941
    [Abstract] [Full Text] [Related]

  • 5. A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura.
    Scully M, McDonald V, Cavenagh J, Hunt BJ, Longair I, Cohen H, Machin SJ.
    Blood; 2011 Aug 18; 118(7):1746-53. PubMed ID: 21636861
    [Abstract] [Full Text] [Related]

  • 6. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
    Bresin E, Gastoldi S, Daina E, Belotti D, Pogliani E, Perseghin P, Scalzulli PR, Paolini R, Marcenò R, Remuzzi G, Galbusera M.
    Thromb Haemost; 2009 Feb 18; 101(2):233-8. PubMed ID: 19190804
    [Abstract] [Full Text] [Related]

  • 7. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.
    Fakhouri F, Vernant JP, Veyradier A, Wolf M, Kaplanski G, Binaut R, Rieger M, Scheiflinger F, Poullin P, Deroure B, Delarue R, Lesavre P, Vanhille P, Hermine O, Remuzzi G, Grünfeld JP.
    Blood; 2005 Sep 15; 106(6):1932-7. PubMed ID: 15933059
    [Abstract] [Full Text] [Related]

  • 8. Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.
    Goyal J, Adamski J, Lima JL, Marques MB.
    J Clin Apher; 2013 Dec 15; 28(6):390-4. PubMed ID: 23857472
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature.
    Ling HT, Field JJ, Blinder MA.
    Am J Hematol; 2009 Jul 15; 84(7):418-21. PubMed ID: 19507208
    [Abstract] [Full Text] [Related]

  • 12. Rituximab as prophylaxis in chronic relapsing thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Montoya RC, Poiesz BJ.
    Blood Coagul Fibrinolysis; 2012 Jun 15; 23(4):338-41. PubMed ID: 22498981
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Rituximab for managing refractory thrombotic thrombocytopenic purpura: a report of three cases].
    Yamanouchi J, Hato T, Miyoshi K, Kobayashi S, Azuma T, Hasegawa H, Yasukawa M.
    Rinsho Ketsueki; 2013 Feb 15; 54(2):205-9. PubMed ID: 23470828
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rituximab as an adjunct to plasma exchange in TTP: a report of 12 cases and review of literature.
    Jasti S, Coyle T, Gentile T, Rosales L, Poiesz B.
    J Clin Apher; 2008 Feb 15; 23(5):151-6. PubMed ID: 18712712
    [Abstract] [Full Text] [Related]

  • 18. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays.
    McDonald V, Liesner R, Grainger J, Gattens M, Machin SJ, Scully M.
    Blood Coagul Fibrinolysis; 2010 Apr 15; 21(3):245-50. PubMed ID: 20083997
    [Abstract] [Full Text] [Related]

  • 19. [Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case].
    Ojeda-Uribe M, Brunot A, Issler M.
    Rev Med Chil; 2005 Nov 15; 133(11):1349-54. PubMed ID: 16446859
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.